PT1511741E - Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos - Google Patents

Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos Download PDF

Info

Publication number
PT1511741E
PT1511741E PT37472693T PT03747269T PT1511741E PT 1511741 E PT1511741 E PT 1511741E PT 37472693 T PT37472693 T PT 37472693T PT 03747269 T PT03747269 T PT 03747269T PT 1511741 E PT1511741 E PT 1511741E
Authority
PT
Portugal
Prior art keywords
analgestics
decahydroisoquinoline
carboxylic acid
ester derivatives
derivatives
Prior art date
Application number
PT37472693T
Other languages
English (en)
Inventor
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1511741E publication Critical patent/PT1511741E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT37472693T 2002-04-26 2003-04-14 Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos PT1511741E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37612002P 2002-04-26 2002-04-26

Publications (1)

Publication Number Publication Date
PT1511741E true PT1511741E (pt) 2013-02-05

Family

ID=29270765

Family Applications (1)

Application Number Title Priority Date Filing Date
PT37472693T PT1511741E (pt) 2002-04-26 2003-04-14 Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos

Country Status (18)

Country Link
US (1) US7247644B2 (pt)
EP (1) EP1511741B1 (pt)
JP (2) JP2005529892A (pt)
KR (1) KR100757787B1 (pt)
CN (1) CN100436446C (pt)
AU (1) AU2003226277B2 (pt)
BR (1) BR0308911A (pt)
CA (1) CA2480026C (pt)
DK (1) DK1511741T3 (pt)
EA (1) EA009526B1 (pt)
ES (1) ES2398225T3 (pt)
IL (1) IL164773A (pt)
MX (1) MXPA04009857A (pt)
NZ (1) NZ535245A (pt)
PT (1) PT1511741E (pt)
SI (1) SI1511741T1 (pt)
WO (1) WO2003091243A1 (pt)
ZA (1) ZA200409552B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1511741E (pt) * 2002-04-26 2013-02-05 Lilly Co Eli Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos
CA2686816A1 (en) 2007-01-16 2008-07-24 The Johns Hopkins University Use of various glutamate receptor antagonists for delaying or preventing platelet activity or for treating or preventing a thrombotic disease or disorder
MX2022016223A (es) * 2020-07-02 2023-02-23 Sea Pharmaceuticals Llc Composiciones farmaceuticas de acido 6-(2-(2h-tetrazol-5-il)etil)- 6-fluorodecahidroisoquinolina-3-carboxilico y derivados de ester del mismo.
MX2023014418A (es) * 2021-06-09 2024-02-13 Proniras Corp Metodos para tratar las convulsiones inducidas por toxinas neurotóxicas.
WO2023130008A2 (en) * 2022-01-01 2023-07-06 Sea Pharmaceuticals Llc Pharmaceutical compositions of 6-(2-(2h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid and derivatives thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US4902695A (en) 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5356902A (en) 1992-11-06 1994-10-18 Eli Lilly And Company Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists
US5446051A (en) 1994-05-31 1995-08-29 Eli Lilly And Company Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
US5767117A (en) 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
TR199902449T2 (xx) 1997-04-07 2000-07-21 Eli Lilly And Company Farmakolojik etkin maddeler.
AU5591900A (en) 1999-07-06 2001-01-22 Eli Lilly And Company Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
DK1200073T3 (da) 1999-07-06 2007-05-07 Lilly Co Eli Selektive iGluR5-receptorantagonister til behandling af migræne
EP1257545A1 (en) 1999-12-22 2002-11-20 Eli Lilly And Company SELECTIVE iGLUR 5? RECEPTOR ANTAGONISTS
AU2001298029A1 (en) 2001-01-05 2003-04-01 Eli Lilly And Company Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
AU2002227020A1 (en) 2001-01-05 2002-07-16 Eli Lilly And Company Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
EP1351952A2 (en) 2001-01-05 2003-10-15 Eli Lilly And Company Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
MXPA03005982A (es) 2001-01-05 2003-09-10 Lilly Co Eli Antagonistas de receptores de aminoacidos excitadores.
WO2003082856A1 (en) 2002-03-22 2003-10-09 Eli Lilly And Company Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
PT1511741E (pt) * 2002-04-26 2013-02-05 Lilly Co Eli Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos

Also Published As

Publication number Publication date
EP1511741B1 (en) 2012-12-26
IL164773A (en) 2011-08-31
WO2003091243A1 (en) 2003-11-06
NZ535245A (en) 2007-11-30
EA200401432A1 (ru) 2005-04-28
CA2480026A1 (en) 2003-11-06
US7247644B2 (en) 2007-07-24
ES2398225T3 (es) 2013-03-14
KR100757787B1 (ko) 2007-09-11
WO2003091243A8 (en) 2005-03-31
CA2480026C (en) 2011-06-07
MXPA04009857A (es) 2004-12-07
JP2005529892A (ja) 2005-10-06
EP1511741A1 (en) 2005-03-09
BR0308911A (pt) 2005-01-04
JP2010235623A (ja) 2010-10-21
IL164773A0 (en) 2005-12-18
CN1649862A (zh) 2005-08-03
SI1511741T1 (sl) 2013-02-28
ZA200409552B (en) 2006-02-22
KR20040102171A (ko) 2004-12-03
US20050256155A1 (en) 2005-11-17
AU2003226277A1 (en) 2003-11-10
CN100436446C (zh) 2008-11-26
DK1511741T3 (da) 2013-01-21
AU2003226277B2 (en) 2009-03-26
EA009526B1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
SG107672A1 (en) A method for the esterification of a fatty acid
HRP20050361A2 (en) Synthesis of thiophenecarboxylic acid esters for the production of ramelic acid salts
GB0428508D0 (en) Formulation containing a carboxylic acid or an ester thereof
PL377511A1 (pl) Pochodne kwasu migdałowego
AU2003225651A8 (en) Nematicidal fatty acid and fatty acid ester related compounds
AU2003242328A1 (en) Process for producing fatty acid alkyl ester composition
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
EP1617830A4 (en) ESTERIFIED FATTY ACID COMPOSITION
AU2003237052A8 (en) Process for preparing (r)-aryloxypropionic acid ester derivatives
AU2003287912A1 (en) Dicarboxylic acid derivatives as ppar-agonists
PT1511741E (pt) Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos
IL184848A0 (en) Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester
PL371427A1 (en) New uses of substituted aminoalkanephosphonic acids
GB2375762B (en) Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters
AU2003212351A8 (en) A process for the preparation of cephalosporan acid derivatives from cephalosporin c
AU2003239054A1 (en) A process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof
AU2003235429A1 (en) (2s)-2-ethylphenylpropionic acid derivative
SG107315A1 (en) Use of conjugated linoleic acid derivatives
HK1077806A1 (en) Novel propionic acid derivative
AU2003231527A8 (en) Novel derivatives of carnosic acid
AU2002308823A1 (en) A method of preparing phosphoric ester
AU2003299746A1 (en) Total synthesis of daurichromenic acid
AU2003238065A1 (en) Method for the production of a dicarboxylic acid from acrylic acid
AU2003218273A1 (en) Stereoselective process for the synthesis of (d)-2-amino-5-phenylpentanoic or alkyl ester thereof
AU2001289723A1 (en) Novel use of difluoromalonic acid esters